Pennstreet:
A math whiz, you're not. LOL If ESNR has a multiple of 2.48 of the number of shares of CDEX, then just figure that ESNR reverse splits by a factor of 2.48 to equal the number of shares CDEX has outstanding--then the stock price of ESNR would be 2.48 times greater than it is now. Apples to apples, ESNR trades higher than CDEX. Think about it.
Also, it matters not that the tech of ESNR is different from that of CDEX. The 2 companies are competing in more or less the same arenas-drug detection and analysis, explosive detection, etc. In fact, the ESNR technology, at least at this point, is more versatile and has a wider base of potential applications. Also, though it's not the fault of JB, CDEX has some fences to mend and tech to tweak, while ESNR appears to be in a fast forward mode.
I hold both stocks. I remain hopeful that JB can undo the mess created by MP and TS. And I certainly do not think that JB has anything to do with the past history of CDEX, other than being a screwed over shareholder like you and me. I do not know why CDEX retained McCommon. Maybe you can shed some light on this.